Enhanced expression of mRNAs of antisecretory factor-1, gp96, DAD1 and CDC34 in human hepatocellular carcinomas

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1536, Issue 1, 2001, Pages 1-12

  Tanaka, Kenji ^a   Kondoh, Nobuo ^b   Shuda, Masahiro ^a   Matsubara, Osamu ^b   Imazeki, Nobuo ^b   Ryo, Akihide ^a   Wakatsuki, Toru ^b   Hada, Akiyuki ^b   Goseki, Narihide ^a   Igari, Toru ^a   Hatsuse, Kazuo ^b   Aihara, Tsukasa ^b   Horiuchi, Sankichi ^a   Yamamoto, Naoki ^a   Yamamoto, Mikio ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

Author keywords

Differential display; Differential gene expression; Hepatocellular carcinoma; Immunohistochemistry; Northern blot analysis; Sodium butyrate

Indexed keywords

ALPHA FETOPROTEIN; BUTYRIC ACID; CELL CYCLE PROTEIN; COMPLEMENTARY DNA; GLYCOPROTEIN GP 96; MESSENGER RNA; PROTEIN CDC34; PROTEIN DAD1; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER GROWTH; CELL DIFFERENTIATION; CELL NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOPLASM; FEMALE; GENE EXPRESSION; GENE OVEREXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION;

ADULT; AGED; ANTIGENS, NEOPLASM; APOPTOSIS REGULATORY PROTEINS; BLOTTING, NORTHERN; CARCINOMA, HEPATOCELLULAR; DISEASE PROGRESSION; DNA, COMPLEMENTARY; FEMALE; GENETIC MARKERS; HUMANS; IMMUNOHISTOCHEMISTRY; LIGASES; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; RNA, MESSENGER; TUMOR CELLS, CULTURED; UBIQUITIN-PROTEIN LIGASE COMPLEXES; UBIQUITIN-PROTEIN LIGASES; UP-REGULATION;

EID: 0035971905     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(01)00026-6     Document Type: Article

References (67)

1. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma
2. Serum antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma
3. Hepatic tumours in ducks fed a low level of toxic groundnut meal
4. Effect of ethanol exposure during embryogenesis and the neonatal period on the incidence of hepatoma in C3H male mice
5. Iron-loading, fibrosis, and hepatic carcinogenesis
6. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements
7. In vitro tumorigenicity of hepatitis B virus DNA and HBx protein
8. Properties of tumour suppressor p53 in murine hepatocyte lines transformed by hepatitis B virus X protein
9. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice
10. c-myc gene amplification during hepatocarcinogenesis by a choline-devoid diet
11. Activating mutations of the c-Ha-ras protooncogene in chemically induced hepatomas of the male B6C3 F1 mouse
12. Investigation of parameters associated with activity of the Kirsten-ras, Harvey-ras, and myc oncogenes in normal rat livers
13. Activated N-ras gene was found in human hepatoma tissue but only in a small fraction of the tumor cells
14. Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma
15. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
16. p53 gene mutation spectrum in hepatocellular carcinoma
17. Aberrations of the tumor suppressor p53 and retinoblastoma genes in human hepatocellular carcinomas
18. Identification and characterization of genes associated with human hepatocellular carcinogenesis
19. A method to isolate differentially expressed genes by displaying specific inner portion of cDNA fragments
20. Differential expression of S19 ribosomal protein, laminin-binding protein, and human lymphocyte antigen class I messenger RNAs associated with colon carcinoma progression and differentiation
21. Structure and expression of the cyclin A gene in human primary liver cancer. Correlation with flow cytometric parameters
22. Reciprocal regulation of alpha-fetoprotein and albumin gene expression by butyrate in human hepatoma cells
23. Gp96/GRP94 is a putative high density lipoprotein-binding protein in liver
24. Tumor-specific cell surface expression of the KDEL containing, endoplasmic reticular heat shock protein gp96
25. Transcriptional regulation of two genes specifically induced by glucose starvation in a hamster mutant fibroblast cell line
26. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer
27. The endoplasmic reticular heat shock protein gp96 is transcriptionally upregulated in interferon-treated cells
28. Interleukin-6 upregulates GP96 expression in breast cancer
29. The endoplasmic reticulum stress protein GRP94, in addition to BiP, associates with unassembled immunoglobulin chains
30. Human homologue of murine tumor rejection antigen gp96: 5′-regulatory and coding regions and relationship to stress-induced proteins
31. The presence of malfolded proteins in the endoplasmic reticulum signals the induction of glucose-regulated proteins
32. Tumour rejection antigens of the hsp90 family (gp96) closely resemble tumour-associated heparanase enzymes
33. Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
34. Expression of the 100-kDa glucose-regulated protein (GRP100/endoplasmin) is associated with tumorigenicity in a model of rat colon adenocarcinoma
35. The endoplasmic reticulum chaperone glycoprotein GRP94 with Ca(2+)-binding and antiapoptotic properties is a novel proteolytic target of calpain during etoposide-induced apoptosis
36. Tumor rejection antigens of chemically induced sarcomas of inbred mice
37. Expression of a shared tumor-specific antigen by two chemically induced BALB/c sarcomas
38. Individually distinct transplantation antigens of chemically induced mouse tumors
39. Ubiquitination of the G1 cyclin Cln2p by a Cdc34p-dependent pathway
40. p34Cdc28-mediated control of Cln3 cyclin degradation
41. The B-type cyclin kinase inhibitor p40SIC1 controls the G1 to S transition in S. cerevisiae
42. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27
43. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence
44. Reduced expression of the cell cycle inhibitor p27 Kip1 in non-small cell lung carcinoma: A prognostic factor independent of Ras
45. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
46. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
47. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
48. Reduced expression of cyclin-dependent kinase inhibitor p27Kip1 is associated with advanced stage and invasiveness of gastric carcinomas
49. Identification of the ubiquitin carrier proteins, E2s, involved in signal-induced conjugation and subsequent degradation of IkappaBalpha
50. Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation
51. Association of human ubiquitin-conjugating enzyme CDC34 with the mitotic spindle in anaphase
52. Molecular cloning and expression of a pituitary gland protein modulating intestinal fluid secretion
53. Effects of the antisecretory factor in pigs
54. Molecular cloning and expression of a multiubiquitin chain binding subunit of the human 26S protease
55. How proteolysis drives the cell cycle
56. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway
57. Homologues of 26S proteasome subunits are regulators of transcription and translation
58. Novel regulation of the helix-loop-helix protein Id1 by S5a, a subunit of the 26 S proteasome
59. Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver
60. Molecular cloning of a human cDNA encoding a novel protein, DAD1, whose defect causes apoptotic cell death in hamster BHK21 cells
61. Induction of apoptosis in prostatic tumor cell line DU145 by staurosporine, a potent inhibitor of protein kinases
62. DAD1, the defender against apoptotic cell death, is a subunit of the mammalian oligosaccharyltransferase
63. Inhibition of N-linked glycosylation induces early apoptosis in human promyelocytic HL-60 cells
64. Mutational hotspot in the p53 gene in human hepatocellular carcinomas
65. p53 gene mutation spectrum in hepatocellular carcinoma
66. Genetic alterations in the 61st codon of the H-ras oncogene isolated from archival sections of hepatic hyperplasias, adenomas and carcinomas in control groups of B6C3F1 mouse bioassay studies conducted from 1979 to 1986
67. Low incidence of point mutation of c-Ki-ras and N-ras oncogenes in human hepatocellular carcinoma